Former Chief Medical Officer · Enliven Therapeutics, Inc. (ELVN)

Willem Scheele

A named executive officer of Enliven Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$368,402

Salary $110,265Stock awards $0

FY2019: $1,063,194

3rd of 3 named executive officers at Enliven Therapeutics by FY2020 total.

3 named officers on file for Enliven Therapeutics, FY2020

Willem Scheele’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Enliven Therapeutics’s whole pay program stands against its peers

  • Enliven Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ELVN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 18, 2021 (DEF 14A).

Free

Get Willem Scheele’s full pay file as a PDF — free

More than this page: up to 10 years of Willem’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Willem Scheele compensation by year

Enliven Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Enliven Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$282,386$110,265
Bonus$67,900$0
Stock awards$0$0
Option awards$708,330$0
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$4,578$258,137
Total$1,063,194$368,402

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Enliven Therapeutics, Inc. DEF 14A filed May 18, 2021, accession 0001193125-21-165316, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Enliven Therapeutics, Inc. filed document, accession 0001193125-21-165316. Every figure is read from that document and cited to the page and table it appears in. Filed May 18, 2021.

$1.1M
$368K
FY19
FY20
SalaryBonusOption awardsAll other

Enliven Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Rahul BallalPresident and Chief Executive Officer$625,596
Michael GrayChief Financial Officer and Chief Operating Officer$541,426
Willem Scheele · this pageFormer Chief Medical Officer$368,402

The full Enliven Therapeutics compensation record

free company brief

This page is one person within Enliven Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Enliven Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Willem Scheele's compensation dossier · One-time report. No refunds.